Proteostasis disruption and senescence in Alzheimer’s disease pathways to neurodegeneration
Brain Research,
Journal Year:
2024,
Volume and Issue:
1845, P. 149202 - 149202
Published: Aug. 30, 2024
Language: Английский
Diastolic dysfunction in Alzheimer’s disease model mice is associated with Aβ-amyloid aggregate formation and mitochondrial dysfunction
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: July 19, 2024
Alzheimer's
Disease
(AD)
is
a
progressive
neurodegenerative
disease
caused
by
the
deposition
of
Aβ
aggregates
or
neurofibrillary
tangles.
AD
patients
are
primarily
diagnosed
with
concurrent
development
several
cardiovascular
dysfunctions.
While
few
studies
have
indicated
presence
intramyocardial
aggregates,
none
performed
detailed
analyses
for
pathomechanism
cardiac
dysfunction
in
patients.
This
manuscript
used
aged
APPSWE/PS1
Tg
and
littermate
age-matched
wildtype
(Wt)
mice
to
characterize
analyze
associated
pathophysiology.
Detailed
assessment
functional
parameters
demonstrated
diastolic
hearts
compared
Wt
hearts.
Muscle
function
evaluation
showed
impairment
(decreased
exercise
tolerance
muscle
strength)
mice.
Biochemical
histochemical
analysis
revealed
aggregate
accumulation
myocardium.
also
histopathological
remodeling
(increased
collagen
myocyte
cross-sectional
area).
Additionally,
altered
mitochondrial
dynamics,
reduced
antioxidant
protein
levels,
impaired
proteostasis
developed
decreased
OXPHOS
PDH
complex
expressions,
ETC
activities,
respiration.
Our
results
that
defects
respiration
which
may
collectively
lead
myocardial
pathological
remodeling.
Language: Английский
How do neurons age? A focused review on the aging of the microtubular cytoskeleton
Brad Richardson,
No information about this author
Thomas Goedert,
No information about this author
Shmma Quraishe
No information about this author
et al.
Neural Regeneration Research,
Journal Year:
2023,
Volume and Issue:
19(9), P. 1899 - 1907
Published: Dec. 14, 2023
Aging
is
the
leading
risk
factor
for
Alzheimer's
disease
and
other
neurodegenerative
diseases.
We
now
understand
that
a
breakdown
in
neuronal
cytoskeleton,
mainly
underpinned
by
protein
modifications
to
destabilization
of
microtubules,
central
pathogenesis
disease.
This
accompanied
morphological
defects
across
somatodendritic
compartment,
axon,
synapse.
However,
knowledge
what
occurs
microtubule
cytoskeleton
morphology
neuron
during
physiological
aging
comparatively
poor.
Several
recent
studies
have
suggested
there
an
age-related
increase
phosphorylation
key
stabilizing
tau,
modification,
which
known
destabilize
indicates
potentially
structures
reliant
on
become
functionally
compromised
normal
aging.
The
current
literature
shows
reductions
synaptic
spine
density
shifts
conformation
might
explain
functional
deficits.
microtubular
actin
with
increasing
age
extremely
limited.
When
considering
regression
dendrites
loss
dendritic
length
volume
reported
whilst
reduction
soma
volume/size
often
seen.
research
into
cytoskeletal
change
limited
handful
demonstrating
mislocalizations
microtubule-associated
proteins
just
one
study
directly
exploring
integrity
microtubules.
In
axonal
diameter
appearance
swellings
but
like
dendrites,
investigates
microtubules
others
reporting
or
mislocalization
proteins.
Though
these
are
general
trends
reported,
clear
disparities
between
model
organisms
brain
regions
worthy
further
investigation.
Additionally,
longitudinal
neuronal/cytoskeletal
should
also
investigate
whether
changes
contribute
not
vulnerability
decline
nervous
system
function
behavioral
output
all
experience.
will
highlight
utility,
if
any,
fortification
promotion
healthy
potential
protection
against
review
seeks
summarize
currently
about
hope
uncovering
mechanisms
underpinning
Language: Английский
Amyloid-β Pathology Is the Common Nominator Proteinopathy of the Primate Brain Aging
Journal of Alzheimer s Disease,
Journal Year:
2024,
Volume and Issue:
100(s1), P. S153 - S164
Published: July 19, 2024
Senile
plaques,
mainly
diffuse,
and
cerebral
amyloid-β
(Aβ)
angiopathy
are
prevalent
in
the
aging
brain
of
non-human
primates,
from
lemurs
to
Hominidae.
Aβ
but
not
hyper-phosphorylated
tau
(HPtau)
pathology
is
common
nominator
proteinopathy
primate
aging.
The
abundance
well
tolerated,
impact
on
cognitive
functions
usually
limited
particular
tasks.
In
contrast,
human
characterized
by
early
appearance
HPtau
pathology,
forming
neurofibrillary
tangles,
dystrophic
neurites
neuritic
neuropil
threads,
preceding
deposits
several
decades
its
severity
progressing
selected
nuclei
stem,
entorhinal
cortex,
hippocampus
limbic
system,
neocortex,
other
regions.
Neurofibrillary
tangles
correlate
with
impairment
dementia
advanced
cases.
linked
humans
altered
membrane
protein
lipid
composition,
particularly
involving
rafts.
Although
similar
alterations
unknown
senescence
postulated
cause
activated
β-amyloidogenic
pathway,
prevailing
signature
Language: Английский
Multi Layered Omics Approaches Reveal Glia Specific Alterations in Alzheimer's Disease: A Systematic Review and Future Prospects
Özkan İş,
No information about this author
Yuhao Min,
No information about this author
Xue Wang
No information about this author
et al.
Glia,
Journal Year:
2024,
Volume and Issue:
73(3), P. 539 - 573
Published: Dec. 9, 2024
Alzheimer's
disease
(AD)
is
the
most
common
neurodegenerative
dementia
with
multi-layered
complexity
in
its
molecular
etiology.
Multiple
omics-based
approaches,
such
as
genomics,
epigenomics,
transcriptomics,
proteomics,
metabolomics,
and
lipidomics
are
enabling
researchers
to
dissect
this
complexity,
uncover
a
plethora
of
alterations
yielding
insights
into
pathophysiology
disease.
These
approaches
reveal
multi-omics
essentially
all
cell
types
brain,
including
glia.
In
systematic
review,
we
screen
literature
for
human
studies
implementing
any
omics
approach
within
last
10
years,
discover
AD-associated
perturbations
brain
glial
cells.
The
findings
from
over
200
AD-related
reviewed
under
four
different
categories:
microglia,
oligodendrocytes,
astrocytes
vascular
Under
each
category,
summarize
shared
unique
identified
cells
through
complementary
approaches.
We
discuss
implications
these
development,
progression
ultimately
treatment
complex
well
directions
future
glia
Language: Английский